Statistics for Olema Pharmaceuticals (id:8274 OLMA)
Valuation metrics
Market cap
494.48M
Enterprise value
310.90M
Trailing P/E (ttm)
-4.10
Forward P/E
-3.27
PEG ratio
-3.27
Price/Sales (ttm)
Price/Book (mrq)
2.48
Enterprise Value/Revenue
Enterprise Value/EBITDA
-2.29
Overview
Shares outstanding
57.30M
Float
29.27M
Shares short
8.31M
% Held by insiders
0.04%
% Held by institutions
1.06%
Average volume (10 days)
522.53K
Average volume (90 days)
Price summary
52-Week low
7.68
52-Week high
16.78
52-Week change
-50.23%
Beta
2.03
50-Day moving average
12.00
200-Day moving average
12.12
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-32.48%
Return on equity
-51.76%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-135,536,000.00
Net income to common (ttm)
-122,679,000.00
Diluted EPS (ttm)
-2.28
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
214.76M
Total cash per share (mrq)
3.75
Total debt (mrq)
562.00K
Total Debt/Equity (mrq)
0.28
Current ratio (mrq)
699.60%
Book value per share (mrq)
3.47
Cash flow
Cash flow statement
-84,532,000.00
Levered free cash flow (LFCF)
-96,655,000.00